Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 2
1951 3
1952 3
1953 1
1954 3
1955 5
1956 3
1957 6
1958 2
1959 2
1960 4
1961 2
1962 1
1964 3
1966 5
1967 8
1968 6
1969 7
1970 2
1971 4
1972 4
1973 6
1974 5
1975 14
1976 7
1977 2
1978 3
1979 5
1980 8
1981 10
1982 7
1983 9
1984 12
1985 12
1986 15
1987 14
1988 17
1989 16
1990 18
1991 24
1992 27
1993 24
1994 31
1995 32
1996 32
1997 37
1998 31
1999 40
2000 37
2001 43
2002 52
2003 46
2004 66
2005 62
2006 55
2007 72
2008 68
2009 79
2010 60
2011 72
2012 61
2013 49
2014 59
2015 63
2016 44
2017 54
2018 58
2019 69
2020 87
2021 96
2022 92
2023 91
2024 90
2025 79
2026 45

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,099 results

Results by year

Filters applied: . Clear all
Page 1
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors.
Liu APY, Li BK, Vasiljevic A, Dewan MC, Tamrazi B, Ertl-Wagner B, Hansford JR, Pfaff E, Mynarek M, Ng HK, Tsang DS, Gottardo NG, Gajjar A, Bouffet E, Dufour C, Pizer B, Schiff D, Jenkinson MD, Lombardi G, Wen PY, van den Bent MJ, Huang A. Liu APY, et al. Among authors: lombardi g. Neuro Oncol. 2024 Dec 5;26(12):2159-2173. doi: 10.1093/neuonc/noae128. Neuro Oncol. 2024. PMID: 39073785 Free PMC article. Review.
Transcriptome analysis reveals tumor microenvironment changes in glioblastoma.
Hoogstrate Y, Draaisma K, Ghisai SA, van Hijfte L, Barin N, de Heer I, Coppieters W, van den Bosch TPP, Bolleboom A, Gao Z, Vincent AJPE, Karim L, Deckers M, Taphoorn MJB, Kerkhof M, Weyerbrock A, Sanson M, Hoeben A, Lukacova S, Lombardi G, Leenstra S, Hanse M, Fleischeuer REM, Watts C, Angelopoulos N, Gorlia T, Golfinopoulos V, Bours V, van den Bent MJ, Robe PA, French PJ. Hoogstrate Y, et al. Among authors: lombardi g. Cancer Cell. 2023 Apr 10;41(4):678-692.e7. doi: 10.1016/j.ccell.2023.02.019. Epub 2023 Mar 9. Cancer Cell. 2023. PMID: 36898379 Free article.
Bone and muscle crosstalk in ageing and disease.
Kirk B, Lombardi G, Duque G. Kirk B, et al. Among authors: lombardi g. Nat Rev Endocrinol. 2025 Jun;21(6):375-390. doi: 10.1038/s41574-025-01088-x. Epub 2025 Feb 26. Nat Rev Endocrinol. 2025. PMID: 40011751 Review.
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
Omuro A, Brandes AA, Carpentier AF, Idbaih A, Reardon DA, Cloughesy T, Sumrall A, Baehring J, van den Bent M, Bähr O, Lombardi G, Mulholland P, Tabatabai G, Lassen U, Sepulveda JM, Khasraw M, Vauleon E, Muragaki Y, Di Giacomo AM, Butowski N, Roth P, Qian X, Fu AZ, Liu Y, Potter V, Chalamandaris AG, Tatsuoka K, Lim M, Weller M. Omuro A, et al. Among authors: lombardi g. Neuro Oncol. 2023 Jan 5;25(1):123-134. doi: 10.1093/neuonc/noac099. Neuro Oncol. 2023. PMID: 35419607 Free PMC article. Clinical Trial.
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).
Bhattoa HP, Vasikaran S, Trifonidi I, Kapoula G, Lombardi G, Jørgensen NR, Pikner R, Miura M, Chapurlat R, Hiligsmann M, Haarhaus M, Evenepoel P, Jørgensen HS, Herrmann M, Kaufman JM, Clark P, Tuzun Ş, Al-Daghri N, Silverman S, Alokail MS, Ormarsdóttir S, Yerro MCP, Matijevic R, Laslop A, da Silva Rosa MMC, Zakraoui L, Burlet N, McCloskey E, Harvey NC, Radermecker RP, Fusaro M, Torre C, Kanis JA, Rizzoli R, Reginster JY, Makris K, Cavalier E. Bhattoa HP, et al. Among authors: lombardi g. Osteoporos Int. 2025 Apr;36(4):579-608. doi: 10.1007/s00198-025-07422-3. Epub 2025 Mar 28. Osteoporos Int. 2025. PMID: 40152990 Free PMC article. Review.
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
Lassman AB, Pugh SL, Wang TJC, Aldape K, Gan HK, Preusser M, Vogelbaum MA, Sulman EP, Won M, Zhang P, Moazami G, Macsai MS, Gilbert MR, Bain EE, Blot V, Ansell PJ, Samanta S, Kundu MG, Armstrong TS, Wefel JS, Seidel C, de Vos FY, Hsu S, Cardona AF, Lombardi G, Bentsion D, Peterson RA, Gedye C, Bourg V, Wick A, Curran WJ, Mehta MP. Lassman AB, et al. Among authors: lombardi g. Neuro Oncol. 2023 Feb 14;25(2):339-350. doi: 10.1093/neuonc/noac173. Neuro Oncol. 2023. PMID: 35849035 Free PMC article. Clinical Trial.
New Insights into Glioblastoma.
Cella E, Bosio A, Lombardi G. Cella E, et al. Among authors: lombardi g. Int J Mol Sci. 2024 Apr 7;25(7):4090. doi: 10.3390/ijms25074090. Int J Mol Sci. 2024. PMID: 38612900 Free PMC article.
Recurrent Glioblastoma: What Is the Route?
Bosio A, Lombardi G. Bosio A, et al. Among authors: lombardi g. Cancers (Basel). 2023 Mar 29;15(7):2028. doi: 10.3390/cancers15072028. Cancers (Basel). 2023. PMID: 37046689 Free PMC article.
2,099 results